October 04, 2024
FDA & Government News
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
September 26, 2024
FDA Approves Osimertinib in Stage III NSCLC After Chemoradiotherapy
The ASCO Post
Advertisement
Recommendations
Advertisement